Maravai LifeSciences Holdings Inc (MRVI)

42.09 +0.17  +0.41% NASDAQ Oct 28, 15:05 USD

Maravai LifeSciences Holdings Gross Profit Margin (Quarterly):

82.77% for June 30, 2021
View 4,000+ financial data types
View Full Chart

Gross Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Gross Profit Margin (Quarterly) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 82.77%
March 31, 2021 79.51%
Dec. 31, 2020 76.21%
Sept. 30, 2020 77.51%
June 30, 2020 54.81%
March 31, 2020 69.99%
Dec. 31, 2019 50.42%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Benchmarks

BioCryst Pharmaceuticals Inc 99.31%
Agios Pharmaceuticals Inc --
Sage Therapeutics Inc 90.99%

Gross Profit Margin (Quarterly) Range, Past 5 Years

Minimum 50.42% Dec 2019
Maximum 82.77% Jun 2021
Average 70.18%

Gross Profit Margin (Quarterly) Related Metrics

Return on Equity 131.1%
Return on Assets 10.42%
Return on Invested Capital 19.54%
Profit Margin (Quarterly) 22.53%
Operating Margin (Quarterly) 70.83%
Return on Net Operating Assets 15.32%


Top Biotech Stocks for Q4 2021
Yahoo 09/20 14:57 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.